Twinlab Consolidated Holdings Stock Performance
| TLCC Stock | USD 0.0006 0.00 0.00% |
On a scale of 0 to 100, Twinlab Consolidated holds a performance score of 9. The entity has a beta of -0.45, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Twinlab Consolidated are expected to decrease at a much lower rate. During the bear market, Twinlab Consolidated is likely to outperform the market. Please check Twinlab Consolidated's variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and rate of daily change , to make a quick decision on whether Twinlab Consolidated's existing price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Twinlab Consolidated Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak fundamental indicators, Twinlab Consolidated exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 424 K | |
| Total Cashflows From Investing Activities | -155 K |
Twinlab |
Twinlab Consolidated Relative Risk vs. Return Landscape
If you would invest 0.05 in Twinlab Consolidated Holdings on September 28, 2025 and sell it today you would earn a total of 0.01 from holding Twinlab Consolidated Holdings or generate 20.0% return on investment over 90 days. Twinlab Consolidated Holdings is currently generating 0.3125% in daily expected returns and assumes 2.5% risk (volatility on return distribution) over the 90 days horizon. In different words, 22% of pink sheets are less volatile than Twinlab, and 94% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Twinlab Consolidated Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Twinlab Consolidated's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Twinlab Consolidated Holdings, and traders can use it to determine the average amount a Twinlab Consolidated's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.125
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TLCC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Twinlab Consolidated is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Twinlab Consolidated by adding it to a well-diversified portfolio.
Twinlab Consolidated Fundamentals Growth
Twinlab Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Twinlab Consolidated, and Twinlab Consolidated fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Twinlab Pink Sheet performance.
| Return On Asset | -0.0653 | |||
| Profit Margin | (0.34) % | |||
| Operating Margin | (0.06) % | |||
| Current Valuation | 124.65 M | |||
| Shares Outstanding | 259.09 M | |||
| Price To Earning | (11.54) X | |||
| Price To Sales | 0.33 X | |||
| Revenue | 72.09 M | |||
| EBITDA | (4.97 M) | |||
| Cash And Equivalents | 142 K | |||
| Total Debt | 102.97 M | |||
| Debt To Equity | 5.29 % | |||
| Book Value Per Share | (0.47) X | |||
| Cash Flow From Operations | 2.65 M | |||
| Earnings Per Share | (0.06) X | |||
| Total Asset | 24.87 M | |||
| Retained Earnings | (215.2 M) | |||
| Current Asset | 32.3 M | |||
| Current Liabilities | 34.02 M | |||
About Twinlab Consolidated Performance
By analyzing Twinlab Consolidated's fundamental ratios, stakeholders can gain valuable insights into Twinlab Consolidated's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Twinlab Consolidated has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Twinlab Consolidated has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Twinlab Consolidated Holdings, Inc., together with its subsidiaries, manufactures, markets, distributes, and retails nutritional supplements and other natural products in the United States and internationally. Twinlab Consolidated Holdings, Inc. was founded in 2013 and is based in Boca Raton, Florida. Twinlab Consolidated operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 62 people.Things to note about Twinlab Consolidated performance evaluation
Checking the ongoing alerts about Twinlab Consolidated for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Twinlab Consolidated help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Twinlab Consolidated has some characteristics of a very speculative penny stock | |
| Twinlab Consolidated has high likelihood to experience some financial distress in the next 2 years | |
| Twinlab Consolidated Holdings currently holds 102.97 M in liabilities with Debt to Equity (D/E) ratio of 5.29, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Twinlab Consolidated has a current ratio of 0.12, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Twinlab Consolidated until it has trouble settling it off, either with new capital or with free cash flow. So, Twinlab Consolidated's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Twinlab Consolidated sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Twinlab to invest in growth at high rates of return. When we think about Twinlab Consolidated's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 72.09 M. Net Loss for the year was (14.94 M) with profit before overhead, payroll, taxes, and interest of 16.58 M. | |
| About 82.0% of Twinlab Consolidated outstanding shares are owned by corporate insiders |
- Analyzing Twinlab Consolidated's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Twinlab Consolidated's stock is overvalued or undervalued compared to its peers.
- Examining Twinlab Consolidated's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Twinlab Consolidated's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Twinlab Consolidated's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Twinlab Consolidated's pink sheet. These opinions can provide insight into Twinlab Consolidated's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Twinlab Pink Sheet analysis
When running Twinlab Consolidated's price analysis, check to measure Twinlab Consolidated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twinlab Consolidated is operating at the current time. Most of Twinlab Consolidated's value examination focuses on studying past and present price action to predict the probability of Twinlab Consolidated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twinlab Consolidated's price. Additionally, you may evaluate how the addition of Twinlab Consolidated to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |